147 related articles for article (PubMed ID: 8980403)
1. CAM 17.1--a new diagnostic marker in pancreatic cancer.
Gansauge F; Gansauge S; Parker N; Beger MI; Poch B; Link KH; Safi F; Beger HG
Br J Cancer; 1996 Dec; 74(12):1997-2002. PubMed ID: 8980403
[TBL] [Abstract][Full Text] [Related]
2. A new enzyme-linked lectin/mucin antibody sandwich assay (CAM 17.1/WGA) assessed in combination with CA 19-9 and peanut lectin binding assay for the diagnosis of pancreatic cancer.
Parker N; Makin CA; Ching CK; Eccleston D; Taylor OM; Milton JD; Rhodes JM
Cancer; 1992 Sep; 70(5):1062-8. PubMed ID: 1515982
[TBL] [Abstract][Full Text] [Related]
3. Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer.
Akashi T; Oimomi H; Nishiyama K; Nakashima M; Arita Y; Sumii T; Kimura T; Ito T; Nawata H; Watanabe T
Pancreas; 2003 Jan; 26(1):49-55. PubMed ID: 12499917
[TBL] [Abstract][Full Text] [Related]
4. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
[TBL] [Abstract][Full Text] [Related]
5. Expression of cathepsin E in pancreas: a possible tumor marker for pancreas, a preliminary report.
Azuma T; Hirai M; Ito S; Yamamoto K; Taggart RT; Matsuba T; Yasukawa K; Uno K; Hayakumo T; Nakajima M
Int J Cancer; 1996 Aug; 67(4):492-7. PubMed ID: 8759606
[TBL] [Abstract][Full Text] [Related]
6. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers.
Koopmann J; Buckhaults P; Brown DA; Zahurak ML; Sato N; Fukushima N; Sokoll LJ; Chan DW; Yeo CJ; Hruban RH; Breit SN; Kinzler KW; Vogelstein B; Goggins M
Clin Cancer Res; 2004 Apr; 10(7):2386-92. PubMed ID: 15073115
[TBL] [Abstract][Full Text] [Related]
7. The clinical relevance of the tumor marker CA 19-9 in the diagnosing and monitoring of pancreatic carcinoma.
Safi F; Roscher R; Beger HG
Bull Cancer; 1990; 77(1):83-91. PubMed ID: 2180502
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Lehtinen L; Carpen O; Andersson LC; Seppänen H; Haglund C
Tumour Biol; 2018 Mar; 40(3):1010428318761494. PubMed ID: 29542402
[TBL] [Abstract][Full Text] [Related]
9. ErbB2 oncogene antibodies differentiate between the normal and diseased pancreas, and between chronic pancreatitis and pancreatic cancer.
Standop J; Schneider M; Ulrich A; Mathiak G; Brand RE; Buechler MW; Pour PM
Oncol Rep; 2004 Dec; 12(6):1309-15. PubMed ID: 15547756
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer.
Kuhlmann KF; van Till JW; Boermeester MA; de Reuver PR; Tzvetanova ID; Offerhaus GJ; Ten Kate FJ; Busch OR; van Gulik TM; Gouma DJ; Crawford HC
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):886-91. PubMed ID: 17507610
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.
Uno K; Azuma T; Nakajima M; Yasuda K; Hayakumo T; Mukai H; Sakai T; Kawai K
J Gastroenterol Hepatol; 2000 Nov; 15(11):1333-8. PubMed ID: 11129230
[TBL] [Abstract][Full Text] [Related]
12. Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis. A comparative study with CA 19-9.
Slesak B; Harlozinska-Szmyrka A; Knast W; Sedlaczek P; van Dalen A; Einarsson R
Cancer; 2000 Jul; 89(1):83-8. PubMed ID: 10897004
[TBL] [Abstract][Full Text] [Related]
13. [Monoclonal antibody SPan-1 in the diagnosis of exocrine pancreatic adenocarcinoma].
Frena A; Mazziotti A; La Guardia G; Martin F
Chir Ital; 2000; 52(4):369-77. PubMed ID: 11190527
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer.
Kawa S; Tokoo M; Hasebe O; Hayashi K; Imai H; Oguchi H; Kiyosawa K; Furuta S; Homma T
Br J Cancer; 1994 Sep; 70(3):481-6. PubMed ID: 8080734
[TBL] [Abstract][Full Text] [Related]
16. Is zinc concentration in pancreatic fluid a marker for pancreatic diseases?
Pungpapong S; Scolapio JS; Woodward TA; Wallace MB; Raimondo M
JOP; 2005 Sep; 6(5):425-30. PubMed ID: 16186663
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.
Reubi JC; Waser B; Friess H; Büchler M; Laissue J
Gut; 1998 Apr; 42(4):546-50. PubMed ID: 9616318
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas.
Wang Y; Gao J; Li Z; Jin Z; Gong Y; Man X
Int J Cancer; 2007 Dec; 121(12):2716-22. PubMed ID: 17708554
[TBL] [Abstract][Full Text] [Related]
19. Trefoil factor family peptides in normal and diseased human pancreas.
Guppy NJ; El-Bahrawy ME; Kocher HM; Fritsch K; Qureshi YA; Poulsom R; Jeffery RE; Wright NA; Otto WR; Alison MR
Pancreas; 2012 Aug; 41(6):888-96. PubMed ID: 22286382
[TBL] [Abstract][Full Text] [Related]
20. Blood-group sialyl-Tn antigen is more specific than Tn as a tumor marker in the pancreas.
Ching CK; Holmes SW; Holmes GK; Long RG
Pancreas; 1994 Nov; 9(6):698-702. PubMed ID: 7846011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]